Immunocore Holdings (IMCR)

Immunocore Holdings (IMCR) Stock Price & Analysis


IMCR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$41.25 - $69.06
Previous Close$49.5
Average Volume (3M)199.77K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)£332.54M
Total Debt (Recent Filing)£69.30M
Price to Earnings (P/E)-17.4
Nov 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.85
Shares Outstanding48,379,410
10 Day Avg. Volume272,981
30 Day Avg. Volume199,767
Standard Deviation0.15
Financial Highlights & Ratios
Price to Book (P/B)8.07
Price to Sales (P/S)16.59
Price to Cash Flow (P/CF)N/A
P/FCF Ratio404.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside59.63% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Immunocore Holdings’s price range in the past 12 months?
Immunocore Holdings lowest stock price was $41.25 and its highest was $69.06 in the past 12 months.
    What is Immunocore Holdings’s market cap?
    Currently, no data Available
    When is Immunocore Holdings’s upcoming earnings report date?
    Immunocore Holdings’s upcoming earnings report date is Nov 08, 2023 which is in 47 days.
      How were Immunocore Holdings’s earnings last quarter?
      Immunocore Holdings released its earnings results on Aug 10, 2023. The company reported -$0.357 earnings per share for the quarter, beating the consensus estimate of -$0.377 by $0.02.
        Is Immunocore Holdings overvalued?
        According to Wall Street analysts Immunocore Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Immunocore Holdings pay dividends?
          Immunocore Holdings does not currently pay dividends.
          What is Immunocore Holdings’s EPS estimate?
          Immunocore Holdings’s EPS estimate is -$0.32.
            How many shares outstanding does Immunocore Holdings have?
            Immunocore Holdings has 48,088,345 shares outstanding.
              What happened to Immunocore Holdings’s price movement after its last earnings report?
              Immunocore Holdings reported an EPS of -$0.357 in its last earnings report, beating expectations of -$0.377. Following the earnings report the stock price went down -3.671%.
                Which hedge fund is a major shareholder of Immunocore Holdings?
                Among the largest hedge funds holding Immunocore Holdings’s share is Baker Bros Advisors LP. It holds Immunocore Holdings’s shares valued at 151M.


                  Immunocore Holdings Stock Smart Score

                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Immunocore Holdings

                  Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases.


                  Top 5 ETFs holding IMCR

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold IMCR. The ETFs are listed according to market value of IMCR within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Adaptimmune Therapeutics
                  Arrowhead Pharmaceuticals
                  Kura Oncology

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis